Evaluation of irritation potential of topical formulations on intact skin

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511826-29-00

Acronym

LT_EUR_MOME/2023

Enrollment

Registered

2024-06-07

Start date

2024-06-20

Completion date

2024-07-22

Last updated

2024-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermal tolerability test: Testing for non-specific, local irritating reactions on intact skin using mean cumulative irritation score (CIS).

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026